Quinuclidine derivatives and medicinal compositions containing the same
US7214687B2 · kind B2 · utility
18Cited by
12References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2006 |
| Grant date | May 8, 2007 |
| Priority date | — |
| Expiry date | Feb 14, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides 3 (R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1 -azoniabicyclo[2.2.2]octane in salt form, pharmaceutical compositions comprising it, and methods of using it for treatment of respiratory disorders, in association with phosphodiesterase 4 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.